Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines
Open Access
- 14 February 2017
- journal article
- review article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 13 (4) , 867-876
Abstract
In the 2015/16 influenza season, the Canadian National Advisory Committee on Immunization (NACI) recommended vaccination with quadrivalent inactivated influenza vaccine (QIV) for infants aged 6–23 months and trivalent inactivated influenza vaccines (TIVs) or QIVs in adults. The objective of this review (GSK study identifier: HO-13-14054) is to examine the epidemiology and disease burden of influenza in Canada and the economic benefits of vaccination. To inform this review, we performed a systematic literature search of relevant Canadian literature and National surveillance data. Influenza B viruses from phylogenetically-distinct lineages (B/Yamagata and B/Victoria) co-circulate in Canada, and are an important cause of influenza complications. Modeling studies, including those postdating the search suggest that switching from TIV to QIV in Canada reduces the burden of influenza and would likely be cost-effective. However, more robust real-world outcomes data is required to inform health policy decision makers on appropriate influenza vaccination strategies for Canada.Keywords
This publication has 67 references indexed in Scilit:
- Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort studyBMC Nephrology, 2013
- Statistical estimates of respiratory admissions attributable to seasonal and pandemic influenza for CanadaInfluenza and Other Respiratory Viruses, 2012
- Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccineVaccine, 2012
- Estimation of the Health Impact and Cost-Effectiveness of Influenza Vaccination with Enhanced Effectiveness in CanadaPLOS ONE, 2011
- Statistical estimates of absenteeism attributable to seasonal and pandemic influenza from the Canadian Labour Force SurveyBMC Infectious Diseases, 2011
- The need for quadrivalent vaccine against seasonal influenzaVaccine, 2010
- Epidemiology of influenza-associated hospitalization in adults, Toronto, 2007/8European Journal of Clinical Microbiology & Infectious Diseases, 2010
- Economic Appraisal of Ontario's Universal Influenza Immunization Program: A Cost-Utility AnalysisPLOS Medicine, 2010
- Critically Ill Patients With 2009 Influenza A(H1N1) Infection in CanadaJAMA, 2009
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004